Steroid regulation of vasoactive intestinal pep tide (VIP)

Stress

Volumn 2, Issue 1, 1997, Pages 79-89

  Rostene, William ^a,b   Montagne, Marie Noelle ^a,b   Dussaillant, M ^b   Gozes, Illana ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Brain; Corticosteroids; Estrogens; Pituitary gland; Vasoactive intestinal peptide

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CYCLIC AMP; DEXAMETHASONE; ESTROGEN; GLUCOCORTICOID RECEPTOR; PROLACTIN; SEROTONIN 1 RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENALECTOMY; BRAIN; HIPPOCAMPUS; HORMONAL REGULATION; HYPOPHYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031432875     PISSN: 10253890     EISSN: None     Source Type: Journal    
DOI: 10.3109/10253899709014739     Document Type: Article

References (77)

1. Alexander, L. D. and Sander, L. D. (1995) "Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHIinduced secretion of ACTH and corticosterone," ffeiiropeptides, 28, 167-173.
2. Alexander, L. D., Evans, K. and Sander, L. D. (1995) "A possible involvement of VIP in feeding-induced secretion of ACTH and corticosterone in the rat," Physiol. Behav., 58, 409-413.
3. Besson, J., Rotsztejn, W., Laburthe, M., Epelbaum, J., Beaudet, A., Kordon, C. and Rosselin, G. (1979) "VIP, brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats," Brain Res., 165, 79-85.
4. Besson, J., Sarrieau, A., Vial, M., Marie, J. C., Rosselin, G. and Rostène, W. (1986) "Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system," Brain Res., 398, 329-336.
5. Bodner, M., Fridkin, M. and Cozes, I. (1985) "VIP and PHM-27 sequences are located on two adjacent exons in the human genome," Proc. Nail. Acad. Sci. USA., 82, 3548-3551.
6. Bohus, B., De Kloet, E. R. and Veldhuis, H. D. (1982) Adrenal steroids and behavioral adaptation, relationship to brain corticosterone receptors. In Ganten, D. and Pfaff, D. (eds), Current Topics in Neiiroendocrinology; (Springer-Verlag, Berlin,) pp. 107-148.
7. Brcnneman, D. E. and Gozes, I. (1996) "A femtomolar-acting neuroprotective peptide," J. Clin. Invest., 97, 2299-2307.
8. Brenneman, D. E., Nicol, T., Warren, D. and Bowers, L. M. (1990) "Vasoactive intestinal peptide, a neurotrophic releasing agent and an astroglial mitogen," J. Neurosci. Res., 25, 386-394.
9. Brenneman, D. E., Westbrook, G. L., Fitzgerald, S. P., Ennist, D. L., Elkins, K. L., Ruff, M. R. and Pert, C. B. (1988) "Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide," Nature, 33, 639-642.
10. Charpentier, G., Bercovici, J. P., Jednak, P., Talbot, J. N., Mutt, V. and Rossclin, G. (1982) "VIP test in prolactinomas and in normal subjects," Biomedicine, 36, .105-107.
11. Chelbi-AIix, M. K., Brouard, A., Boissard, C., Pélaprat, D., Rostène, W. and Thang, M. N. (1994) "Induction by vasoactive intestinal peptide of interfcron ot/β synthesis in glial cells but not in neurons," J. Cell. Pliysiol, 158,47-54.
12. Chew, L. J., Murphy, D. and Carter, D. A. (1994) "Alternatively polyadenylated vasoaclive intestinal peptide mRNAs are differentially regulated at the level of stability," Mol. Eiulocrinol., 8, 603-613.
13. Chew, L. J., Murphy, D. and Carter, D. A. (1994) Regulation of VIP expression in the rat anterior pituitary. In Rosselin, G. (ed.), Vasoactive intestinal peplide, pituitary adenylate cyclase activating polypeptide and related regulatory peptides. (Euroconference, Word Scientific, Singapore), pp. 355-367.
14. Clapp, C., Sears, P. S. and Nicoll, C. S. (1989) "Binding studies with intact'rat prolactin and I6K fragment of the hormone," Endocrinology, 125, 1054-1059.
15. Clopton, J. K. and Gordon, J. H. (1985) "The possible role of 2-hydroxyestradiol in the development of estrogen-induced striatal dopamine receptor hypersensibility," Brain Res., 333, 1-10.
16. Cottrell, G. A., Veldhuis, H. D., Rostène, W. H. and De Kloet, E. R. "(1984) "Behavioral actions of VIP," Netiropeplides, 4,331-341.
17. Dodd, J., Kelly, J. S. and Said, S. I. (1979) "Excitation of CA1 neurons of the rat hippocampus by the octacosapeptide, VIP." Br. J. Pharmacol, 66, 125P.
18. Glowa, J. R., Panlilio, L. V., Brenneman, D. E., Gozes, I., Fridkin, M. and Hill, J. M. (1992) "Learning impairment following intracerebral administration of the HIV envelope protein gp!20 or a VIP antagonist," Brain Res., 570,49-53.
19. Gozes, I. and Brenneman, D. E. (1989) "VIP, molecular biology and neurobiological function," Mol. Neitrobiology, 3, 201-236.
20. Gozes, I. and Shani, Y. (1986) "Hypothalamic VIP-mRNA is increased in lactating rats," Endocrinology, 119, 2497-2501.
21. Gozes, I., Avidor, R., Giladi, E., Shani, Y., McEwen, B. S., Dussaillant, M. and Rostène, W. H. (1994) "Adrenalectomy decreases vasoactive intestinal peptide-mRNA levels in the rat suprachiasmatic nucleus," Neurosci. Lett., 167, 24-28.
22. Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M. and Brenneman, D. E. (1996) "Neuroprotective strategy for Alzheimer disease, intranasal administration of a fatty neuropeptide," Proc. Natl. Acad. Sci. USA, 93,427-32.
23. Gozes, I., Fridkin, M. and Brenneman, D. E. (1995) "A VIP hybrid antagonist, from neurotrophism to clinical applications," Cell. Mol. Neurobiol, 15, 675-687.
24. Gozes, I., Glowa, J., Brenneman, D. E., McCune, S. K., Lee, E. and Westphal, H. (1993) "Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene," J. Mol. Neurosci., 4, 185-193.
25. Cozes, I., Lilling, G., Glazer, R., Ticher, A., Ashkenazi, I. E., Davidson, A., Rubinraut, S., Fridkin, M. and Brenneman, D. E. (1995) "Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors," J. Pharmacol. Exp. Tlier.,213, 161-167.
26. Cozes, I., Shani, Y., Liu, B. and Burbach, J. P. H. (1989) "Diurnal variations in vasoactive intestinal peptide messenger RNA in the suprachiasmatic nucleus of the rat," Neurosci. Res. Commun., 5, 83-86.
27. Cozes, I., Wemer, H., Fawzi, M. A. A., Shani, Y., Fridkin, M. and Koch, Y. (1989) "Estrogen regulation of vasoactive intestinal peptide mRNA.in the rat hypothalamus," J. Mol. Neurosci., 1, 55-61.
28. Harrelson, A. L. and McEwen, B: S. (1987) "Hypophysectomy increases VIP-stimulated cAMP generation in the hippocampus of the rat," J. Neurosci., 7,2807-2810.
29. Harrelson, A. L., Rostène, W. and McEwen, B. S. (1987) "Adrenocortical steroids modify neurotransmitter-stimulated cyclic AMP accumulation in the hippocampus and limbic brain of the rat," J. Neurochem.,4S, 1648-1655.
30. Kasper, S., Popeseu, R. A., Torsello, A., Vrontakis, M. E., Ikejiani, C. and Friesen, H. G. (1992) 'Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by oestrogen in the rat," Endocrinology, 130, 1796-1801.
31. Kalo, Y., Iwasaki, Y., Iwasaki, J., Abe, H., Yanaihara, N. and Imura, H. (1978) "Prolactin release by vasoactive intestinal polypeptide in rats," Endocrinology, 103,554-558.
32. Kuhar, M. J. (1981) "Autoradiographic localization of drug and neurotransmitter receptors in the brain," TINS, 4,60-64.
33. Lam, K. S. L., Srivastava, G. and Tarn, S. P. (1992) "Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary," Neuroendocrinology, 56, 32-37.
34. Lam, K. S. L., Srivastava, G., Lechan, R. M., Lee, T. and Reichlin, S. (1990) "Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary," NeuroenJocrinology, 52,417-421.
35. Lantigua, R. A., Streck, W. F., Lockwood, D. H. and Jacob, L. S. (1980) "Glucocorticoid suppression of pancreatic and pituitary hormones, pancreatic polypeptide, growth hormone and prolactin,".J. Clin. Endocrinol Melab., 50, 298-303.
36. Luine, V. N., Rostène, W., Rhodes, J. and McEwen, B. S. (1984) "Activation of choline acetyltransferase by vasoactive intestinal peptide," J. Ncurochem., 42, 1131-1134.
37. MacLeod, R. M. (1976) "Regulation of prolactin secretion," Front. Nenroendocr.,4, 169-194.
38. Magistretti, P. J., Morrison, J. H., Shoemaker, W. J. and Bloom, F. E. (1981) "Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices, a possible regulatory mechanism for the local control of energy metabolism," Proc. Nail. Acad. Sci. USA., 78,6535-6539.
39. Maletti, M., Rostène, W. H., Carr, L., Scherrer, H., Rotten, D., Kordon, C. and Rosselin, G. (1982) "Interaction between estradiol and prolactin on vasoactive intestinal peptide concentrations in thé hypothalamus and in the anterior pituitary of the female rat," Neurosci Lett, 32, 307-313.
40. Me Culloch, J. and Edvinsson, L. (1980) "Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide," Am. J. Physiol., 238, H449-H456.
41. McEwen, B. S., Davis, P. G., Parsons, B. and Pfaff, D. W. (1979) "The brain as a target for steroid hormone action," Ann. Rev. Neurasd.,2,65-112.
42. McEwen, B. S., De Kloet, E. R. and Rostène, W. (1986) "Adrenal steroid receptors and actions in the nervous system," Physiol. fier., 66, 1121-1188.
43. McEwen, B. S., Zigmond, R. E. and Gcrlach, J. L. (1972) Sites of steroid binding and action in the brain. In Bourne, G. H. (ed), Structure and function of nervous tissue, vol. 5, (Academic, New York), pp. 205-291.
44. McEwen, B. S. (1994) "Corticosteroids and hippocampal plasticity," Ann. NYAcail. Sci., 746, 134-144.
45. McEwen, B. S. and Sapolsky, R. M. (1995) "Stress and cognitive function," Citrr. Opinion in Nenrobiol, 5, 205-216.
46. McEwen, B. S. and Schmeck, H. M. Jr. (1994) The Hostage Brain, (The Rockefeller University Press, New York), pp. 323.
47. McEwen, B. S., Biegon A., Davis, P. G., Krey, L. C., Luine, V. N., McGinnis, M. Y., Paden, C. M., Parsons, B. and Rainbow, T. C. (1982) "Steroid hormones, humoral signals which alter brain cell properties and functions," Rec. Progr. Honn. Res., 38,41-92.
48. Mezey, E. and Kiss, J. Z. (1985) "Vasoactive intestinal peptidecontaining neurons in the paraventricular nucleus may participate in regulating prolactin secretion," Proc. Nail. AcaJ. Sci. ' USA; 82, 245-247.
49. Micco, D.I., Meyer, J. S. and McEwen, B. S. (1980) "Effects of corticosterone replacement on the temporal patterning of activity and sleep in adrenalectomized rats," Brain Res., 200, 206-212.
50. Montagne, M. N., Dussaillant, M., Chew, L. J., Bérod, A., Lamberts, S. J., Carter, D. and Rostène, W. (1995) "Estradiol induces vasoactive intestinal peptide and prolactin gene expression in the rat anterior pituitary independently of plasma prolactin levels," J. Neiiroendocrinol., 7,225-231.
51. Montagne, M. N., Vial, M., Joubert-Bression, D. and Rostène, W. (1989) "Hyperprolactinemia-induced modifications in vasoactive intestinal peptide binding site densities in the rat central nervous system and pituitary gland, evidence for an interaction between estradiol-17β and prolactin effects," Brain Res., 485, 258-266.
52. Muccioli, G., Ghe, C. and Di Carlo, R. (1991) "Distribution and characterization of prolactin binding sites in the male and female - rat brain; Effect of hypophysectomy and ovariectomy," Neuroendocrinology, 53,47-53.
53. Nobou, F., Besson, J., Rostène, W. and Rosselin, G. (1985) "Ontogeny of vasoactive intestinal peptide and somatostatin in different structures of the rat brain, effects of hypo- and hypercorticism," Dev. Drain Res., 20, 296-301.
54. Nowak, M., Markowska, A., Nussdorfer, G. G., Tortorella, C. and Malendowicz, L. K. (1994) "Evidence that endogenous vasoactive intestinal peptide (VIP) is involved in the regulation of rat pituitary-adrenocortical function, m vivo studies with a VIP antagonist," Neuropeptides, 27,297-303.
55. Pei, L. (1996) "Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene," J. Biol. Client., 271,20879-20884.
56. Pfaff, D. and Keiner, M. (1973) "Atlas of estradiol concentrating cells in the central nervous system of the female rat," J. Comp. Neural., 151, 121-158.
57. Pizzi, M., Rubessa, S., Simonazzi, E., Zanagnolo, V., Falsetti, L., Memo, M. and Spano, P. F. (1992) "Requirement of estrogens for sensitivity of prolactin cells to vasoactive intestinal peptide in rats and man," J Eiulocr., 132, 311-316.
58. Rainbow, T. C., Bleisch, W., Biegon, A. and McEwen, B. S. (1982) "Quantitative densitometry of neurotransmitter receptors," J. Neurosci. Melh., 5, 127-138.
59. Reichlin, S. (1988) "Neuroendocrine significance of vasoactive intestinal polypeptide," Ann. NYAcad. Sci., 521,431-449.
60. Riou, F., Cespuglio, R. and Jouvet, M. (1982) "Endogenous peptides and sleep in the rat, the hypnogenic properties of vasoactive intestinal peptide," Neuropepiides, 2, 265-277.
61. Rosselin, G., Maletti, M., Besson, J. and Rostène, W. (1982) "A new neuroregulator,' the vasoactive intestinal peptide or VIP," Mol. Cell. Endocrinol',21, 243-262.
62. Rostène, W. H. (1984) "Neurobiological and neuroendocrine functions of VIP," Prog. NeiirobioL, 22, 103-129.
63. Rostène, W., Dussaillant, M., Denis, P., Gozes, I., Montagne, M. N. and Bérod, A. (1992) "Distribution and regulation of vasoactive intestinal peptide mRNA and binding sites in the mammalian eye, brain and pituitary," Biochem. Res., 2, 63-69.
64. Rostène, W. H., Fischette, C. T. and McEwen, B. S. (1983) "Modulation by VIP of serotonin 1 receptors in membranes from rat hippocampus," J. Neitrosci., 3, 2414-2419.
65. Rostène, W. H., Fischette, C. T., Rainbow, T. C. and McEwen, B. S. (1983) "Modulation by vasoactive intestinal peptide of serotonin 1 receptors in the dorsal hippocampus of the rat brain, an autoradiographic study," Neitrosci. Lett., 37, 143-148.
66. Rostène, W. H., Fischette, C. T., Dussaillant, M. and McEwen, B. S. (1985) "Adrenal steroid modulation of vasoactive intestinal peptide effect on serotoninl binding sites in the rat brain shown by in vitro quantitative autoradiography," Neuroendocrinology, 40, 129-134.
67. Rotsztejn, W., Benoist, L., Besson, J. and Duval, J. (1980) "Regulation par la dexamethasone de la libération de prolactine induite par le VIP," C. R. Acad. Sci. Paris, 290, 791-793.
68. Rotsztejn, W. H., Besson, J., Briaud, B., Gagnant, L., Rosselin, G. and Rosselin, G. (1980) "Effects of steroids on vasoactive intestinal peptide in discrete brain regions and peripheral tissues," Neuroeiulocrino!ogyr31,287-291.
69. Rotsztejn, W. H., Dussaillant, M., Nobou, F. and Rosselin, G. (1981) "Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture," Proc. Nail. Acad. Sci. USA., 78, 7584-7588.
70. Rubcrg, M., Rotsztejn, W. H., Arancibia, S., Besson, J. and Enjalbert, A. (1978) "Stimulation of prolactin release by VIP," Eur. J. Plmrmacol., 51, 319-320.
71. Said, S. I. and Mutt, V. (1970) "Polypeptide with broad biolosical activity, isolation from small intestine," Science, 169, 1217-1218.
72. Siaud, P., Manzoni, O., Balmefrezol, M., Barbanel, G., Assenmacher, I. and Alonso, G. (1989) "The organization of prolactin-likeimmunoreactivive neurons in the rat central nervous system," Cell Tissue Research, 255, 107-115.
73. Stella, N. and Magistretti, P. J. (1996) "VIP and PACAP potentiate the glutamate-evoked release of arachidonic acid from mouse cortical neurons," J. Biol. Cliem., 271, 23705-23710.
74. Taylor, A. D., Cowell, A. M., Flower, R. J. and Buckingham, J. C. (1995K'Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms," Neiiroeiulocrinology, 62,530-542.
75. Wiesz, J. and Crow ley, W. R. (19S6) "Catecholestrogen formation by the CNS, Regional distribution of estrogen- !A hydroxylase activity in rat brain," Neiiroeiulocrinology, 43,543-549.
76. Wollman, Y., Lilling, G., Goldstein, M. N., Fridkin, M. and Gozes, I. (1993) "Vasoactive intestinal peptide, a growth promoter in neuroblastoma cells," Brain Res., 624, 339-341.
77. Zhou, J. N., Hofman, M. A. and Swaab, D. F. (1995) "VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease," Neurobiol Aging, 16, 571-576.